共 50 条
- [1] Pemetrexed and carboplatin plus bevacizumab for advanced non-squamous non-small cell lung cancer (NSCLC): Preliminary resultsJOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)Patel, J. D.Hensing, T. A.Villafor, V.Hart, E.Bonomi, P.
- [2] Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly PatientsANTICANCER RESEARCH, 2018, 38 (06) : 3779 - 3784Takeoka, HiroakiYamada, KazuhikoNaito, YoshikoMatsuo, NorikazuIshii, HidenobuTokito, TakaakiAzuma, KoichiIchiki, MasaoHoshino, Tomoaki
- [3] Phase II trial of carboplatin and pemetrexed plus bevacizumab with maintenance bevacizumab as first-line treatment for elderly patients with advanced non-squamous non-small cell lung cancerJOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Takeoka, HiroakiYamada, KazuhikoIshii, HidenobuTokito, TakaakiAzuma, KoichiNaito, YoshikoMatsuo, NorikazuIchiki, MasaoHoshino, Tomoaki
- [4] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung CancerANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987Yoshida, HironoriKim, Young HakSakamori, YuichiNagai, HirokiOzasa, HiroakiKaneda, ToshihikoYoshioka, HiroshigeNakagawa, HiroakiTomii, KeisukeOkada, AsukaYoshimura, KenichiHirabayashi, MasatakaHirai, Toyohiro
- [5] Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancerEUROPEAN JOURNAL OF CANCER, 2016, 58 : 30 - 37Karayama, MasatoInui, NaokiFujisawa, TomoyukiEnomoto, NoriyukiNakamura, YutaroKuroishi, ShigekiYokomura, KoshiKoshimizu, NaokiSato, MasakiToyoshima, MikioShirai, ToshihiroMasuda, MasafumiYamada, TakashiImokawa, ShiroSuda, Takafumi
- [6] Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancerONCOLOGY LETTERS, 2014, 8 (06) : 2453 - 2457Yokoi, TakashiTorii, YoshitaroKatashiba, YuichiSugimoto, HiroyukiTanijiri, TsutomuOgata, MakotoInagaki, NorikoKibata, KayokoHayashi, MinaNiki, MaikoShimizu, ToshikiMiyara, TakayukiKurata, TakayasuNomura, Shosaku
- [7] Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung CancerJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) : 3284 - 3289Patel, Jyoti D.Hensing, Thomas A.Rademaker, AlfredHart, Eric M.Blum, Matthew G.Milton, Daniel T.Bonomi, Philip D.
- [8] COST UTILITY ANALYSIS OF FIRST-LINE PACLITAXEL WITH CARBOPLATIN AND BEVACIZUMAB FOLLOWED BY MAINTENANCE BEVACIZUMAB VERSUS PEMETREXED WITH CARBOPLATIN FOLLOWED BY MAINTENANCE PEMETREXED IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER IN LEBANONVALUE IN HEALTH, 2018, 21 : S47 - S47Tfayli, A.Elias, F.Farhat, F.Slim, R.Hallal, Z.Maatouk, L.Ibrahim, A.Anan, I
- [9] Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 studyLUNG CANCER, 2014, 86 (01) : 47 - 53Santoro, ArmandoHillerdal, Gunnar N.Hoeffkenc, GertFavaretto, AdolfoCarrion, Ramon PerezVisseren-Grul, CarlaAmeryckx, SophieHelsberg, KarinSoldatenkova, VictoriaBourayou, NawelSorensen, Jens B.
- [10] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698Guarino, Michael J.Masters, Gregory A.Biggs, David D.